Search Results - "DE KLERK, JOHN M. H"

FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis by Adams, Hugo J. A., Kwee, Thomas C., de Keizer, Bart, Fijnheer, Rob, de Klerk, John M. H., Nievelstein, Rutger A. J.

“…Purpose To systematically review and meta-analyse published data on the diagnostic performance of 18 F-FDG PET/CT in detecting bone marrow involvement in…”
Get full text

Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT by Adams, Hugo J. A., de Klerk, John M. H., Heggelman, Ben G. F., Dubois, Stefan V., Kwee, Thomas C.

“…Purpose To determine the malignancy rate of bone lesions identified on FDG PET/CT in patients who have undergone CT-guided biopsy because of the suspicion of…”
Get full text

Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study by Adams, Hugo J. A., Kwee, Thomas C., Fijnheer, Rob, Dubois, Stefan V., Blase, Peter E., Nievelstein, Rutger A. J., de Klerk, John M. H.

“…Objective To determine the value of visual and quantitative 18  F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) for…”
Get full text

Quantitative classification and radiomics of [18F]FDG-PET/CT in indeterminate thyroid nodules by de Koster, Elizabeth J., Noortman, Wyanne A., Mostert, Jacob M., Booij, Jan, Brouwer, Catherine B., de Keizer, Bart, de Klerk, John M. H., Oyen, Wim J. G., van Velden, Floris H. P., de Geus-Oei, Lioe-Fee, Vriens, Dennis

“…Purpose To evaluate whether quantitative [ 18 F]FDG-PET/CT assessment, including radiomic analysis of [ 18 F]FDG-positive thyroid nodules, improved the…”
Get full text

Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma? by Adams, Hugo J. A., de Klerk, John M. H., Fijnheer, Rob, Heggelman, Ben G. F., Dubois, Stefan V., Nievelstein, Rutger A. J., Kwee, Thomas C.

“…Purpose To determine the prognostic value of tumor-induced cortical bone destruction at computed tomography (CT) in newly diagnosed diffuse large B-cell…”
Get full text

Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastases by Lange, Rogier, ter Heine, Rob, (FF) Knapp, Russ, de Klerk, John M.H, Bloemendal, Haiko J, Hendrikse, N. Harry

“…Abstract Therapeutic phosphonate-based radiopharmaceuticals radiolabeled with beta, alpha and conversion electron emitting radioisotopes have been investigated…”
Get full text

Performance and Prospects of [ 68 Ga]Ga-FAPI PET/CT Scans in Lung Cancer by Borgonje, Paula E, Andrews, Louise M, Herder, Gerarda J M, de Klerk, John M H

“…Fibroblast activation protein (FAP) could be a promising target for tumor imaging and therapy, as it is expressed in >90% of epithelial cancers. A high level…”
Get full text

A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial by van Dodewaard-de Jong, Joyce M., de Klerk, John M. H., Bloemendal, Haiko J., Oprea-Lager, Daniela E., Hoekstra, Otto S., van den Berg, H. Pieter, Los, Maartje, Beeker, Aart, Jonker, Marianne A., O’Sullivan, Joe M., Verheul, Henk M. W., van den Eertwegh, Alfons J. M.

“…Background Rhenium-188-HEDP is a beta-emitting radiopharmaceutical used for palliation of metastatic bone pain. We investigated whether the addition of…”
Get full text

Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET by Adams, Hugo J. A., Kwee, Thomas C., Vermoolen, Malou A., de Keizer, Bart, de Klerk, John M. H., Adam, Judit A., Fijnheer, Rob, Kersten, Marie José, Stoker, Jaap, Nievelstein, Rutger A. J.

“…Objective To assess and compare the value of whole-body MRI with FDG-PET for detecting bone marrow involvement in lymphoma. Methods A total of 116 patients…”
Get full text

Prospective Comparison of [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Patients With Melanoma With Palpable Lymph Node Metastases: Diagnostic Accuracy and Impact on Treatment by BASTIAANNET, Esther, WOBBES, Theo, HOEKSTRA, Otto S, VAN DER JAGT, Eric J, BROUWERS, Adrienne H, KOELEMIJ, Ron, DE KLERK, John M. H, OYEN, Wim J. G, MEIJER, Sybren, HOEKSTRA, Harald J

“…Patients with melanoma with potentially resectable lymph node metastases require accurate staging to prevent unnecessary surgery. [(18)F]Fluorodeoxyglucose…”
Get full text

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise? by Adams, Hugo J A, Kwee, Thomas C, Fijnheer, Rob, Dubois, Stefan V, Nievelstein, Rutger A J, de Klerk, John M H

“…Detection of bone marrow involvement using 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG-PET/CT) has been proposed as a…”
Get more information

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases by Lam, Marnix G. E. H., Dahmane, Amel, Stevens, Wil H. M., van Rijk, Peter P., de Klerk, John M. H., Zonnenberg, Bernard A.

“…Purpose 153 Sm-ethylenediaminetetramethylenephosphonic acid (EDTMP; Quadramet®) is indicated for the treatment of painful bone metastases, whereas zoledronic…”
Get full text

Cytotoxic Effects of the Therapeutic Radionuclide Rhenium-188 Combined with Taxanes in Human Prostate Carcinoma Cell Lines by Lange, Rogier, ter Heine, Rob, van Wieringen, Wessel N, Tromp, Adrienne M, Paap, Mayke, Bloemendal, Haiko J, de Klerk, John M H, Hendrikse, N Harry, Geldof, Albert A

“…Rhenium-188-HEDP is an effective radiopharmaceutical for the treatment of painful bone metastases from prostate cancer. The effectiveness of the β-radiation…”
Get more information

Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG‐PET by Adams, Hugo J.A., de Klerk, John M.H., Fijnheer, Rob, Dubois, Stefan V., Nievelstein, Rutger A.J., Kwee, Thomas C.

Get full text

False‐negative FDG‐PET in histologically proven extensive large cell bone marrow involvement in diffuse large B‐cell lymphoma by Adams, Hugo J.A., de Klerk, John M.H., Fijnheer, Rob, Dubois, Stefan V., Nievelstein, Rutger A.J., Kwee, Thomas C.

Get full text

Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match? by Adams, Hugo J. A., Kwee, Thomas C., Fijnheer, Rob, Dubois, Steven V., Nievelstein, Rutger A. J., de Klerk, John M. H.

“…Purpose To directly compare visual and quantitative 18 F-fluoro-2-deoxy- d -glucose positron emission tomography/computed tomography (FDG-PET/CT) to bone…”
Get full text

Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value? by Adams, Hugo J A, de Klerk, John M H, Fijnheer, Rob, Heggelman, Ben G F, Dubois, Stefan V, Nievelstein, Rutger A J, Kwee, Thomas C

“…This study aimed to determine the prognostic value of residual anatomical disease, including its size and reduction relative to baseline, in diffuse large…”
Get full text

Radiation-Induced Giant Cell Granuloma Mimicking Relapsed Hodgkin Lymphoma at FDG-PET/CT by Adams, Hugo J. A., de Klerk, John M. H., Regelink, Josien C., Heggelman, Ben G. F., Dubois, Stefan V., Kwee, Thomas C.

“…A 22-year-old woman was diagnosed with intermediate risk stage II Hodgkin lymphoma and treated with three cycles of adriamycin, bleomycin, vinblastine, and…”
Get full text

Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer by van Kalmthout, Ludwike W M, van Melick, Harm H E, Lavalaye, Jules, Meijer, Richard P, Kooistra, Anko, de Klerk, John M H, Braat, Arthur J A T, Kaldeway, H Peter, de Bruin, Peter C, de Keizer, Bart, Lam, Marnix G E H

“…Prospective validation of Ga prostate specific membrane antigen positron emission tomography/computerized tomography is lacking in initial staging of prostate…”
Get full text

Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma? by van Hamersvelt, Hanneke P, Kwee, Thomas C, Fijnheer, Rob, Beek, Frederik J A, de Klerk, John M H, Nievelstein, Rutger A J

“…To determine whether full-dose contrast-enhanced computed tomography (CT) (CECT) can be omitted from an F-fluoro-2-deoxy-D-glucose (FDG) positron emission…”
Get full text